Archive - June 2019
Syncona start-up Quell Therapeutics appoints chief exec
Aimmune wins over ICER for peanut allergy product
Sobi takes ownership of rare disease drug Gamifant for $518m
£1 billion cuts to public health must be reversed, say charities
EMD Serono allies with ‘free sequencing’ firm Nebula
Type 1 diabetes prevention promise sends Provention Bio soaring
Orkambi row: government now considering Crown Use licensing
Lilly’s Trulicity cuts heart and kidney risks in diabetes by 12%